PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT)

268 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share as of Q4 2024.
PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) has 237 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 77.7M shares of 79.2M outstanding shares and own 98.1% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (9.18M shares), BlackRock, Inc. (7.9M shares), RTW INVESTMENTS, LP (7.39M shares), ARMISTICE CAPITAL, LLC (6.38M shares), WELLINGTON MANAGEMENT GROUP LLP (4.79M shares), TORONTO DOMINION BANK (3.29M shares), Camber Capital Management LP (3.2M shares), STATE STREET CORP (2.71M shares), JANUS HENDERSON GROUP PLC (2.33M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.8M shares).
This table shows the top 237 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.